Author

C. Chabbert

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

C. K. Hirt· 1 shared D. Auguin· 1 shared E. J. Davies· 1 shared G. Raetsch· 1 shared G. Schwank· 1 shared G. Tornillo· 1 shared H. Kendrick· 1 shared H. Morgan· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. K. Hirt

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Dexamethasone, a direct modulator of AQP2 in Meniere s disease.

R. Mom, J. Robert-Paganin, T. Mom, C. Chabbert, S. Rety, D. Auguin

This study shows dexamethasone directly interacts with AQP2, modulating its water permeability and providing new insights into its mechanism in Meniere's disease treatment.

bioRxiv · Jan 25, 2022 · PreprintBiochemistry

Characterization of HIF-dependent alternative isoforms in pancreatic cancer

P. Markolin, N. Davidson, C. K. Hirt, C. Chabbert, N. Zamboni, G. Schwank, G. Raetsch

The paper identifies HIF-dependent alternative splicing events in pancreatic cancer cells under hypoxia and validates a novel long coding isoform of SLC35A3.

bioRxiv · Feb 14, 2020 · PreprintCell Biology

Generation and characterisation of an estrogen receptor-positive GEMM-derived Pten p53 null transplantable breast tumour model for therapeutic testing

E. J. Davies, H. Morgan, G. Tornillo, C. Chabbert, H. Kendrick, M. J. Ahdesmaki, S. Luke, S. T. Barry, M. J. Smalley

The paper develops a transplantable breast tumour model from an ER+ GEMM to study therapeutic resistance and pathway dependencies in breast cancer.

bioRxiv · Sep 12, 2019 · PreprintCancer Biology